【市場調査レポート】ヒト用ベロ細胞狂犬病ワクチンのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Vero Cell Rabies Vaccines for Human Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。ヒト用ベロ細胞狂犬病ワクチンのグローバル市場インサイト・予測（～2028年） / Global Vero Cell Rabies Vaccines for Human Market Insights, Forecast to 2028 / QY2207E10517資料のイメージです。

• レポートコード：QY2207E10517
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、90ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のヒト用ベロ細胞狂犬病ワクチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヒト用ベロ細胞狂犬病ワクチンの世界市場のxxx％を占める「フリーズドライ粉末」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「暴露前予防」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のヒト用ベロ細胞狂犬病ワクチンの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのヒト用ベロ細胞狂犬病ワクチン市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのヒト用ベロ細胞狂犬病ワクチン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ヒト用ベロ細胞狂犬病ワクチンのグローバル主要メーカーには、Bharat Biotech、Sanofi-Pasteur、Chengda Bio、Prcmise、Zhuoyi Biological、Ningbo Rongan Biological、Indian Immunologicalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ヒト用ベロ細胞狂犬病ワクチン市場は、種類と用途によって区分されます。世界のヒト用ベロ細胞狂犬病ワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
フリーズドライ粉末、液体

【用途別セグメント】
暴露前予防、暴露後予防

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ヒト用ベロ細胞狂犬病ワクチン製品概要
- 種類別市場（フリーズドライ粉末、液体）
- 用途別市場（暴露前予防、暴露後予防）
- 調査の目的
・エグゼクティブサマリー
- 世界のヒト用ベロ細胞狂犬病ワクチン販売量予測2017-2028
- 世界のヒト用ベロ細胞狂犬病ワクチン売上予測2017-2028
- ヒト用ベロ細胞狂犬病ワクチンの地域別販売量
- ヒト用ベロ細胞狂犬病ワクチンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ヒト用ベロ細胞狂犬病ワクチン販売量
- 主要メーカー別ヒト用ベロ細胞狂犬病ワクチン売上
- 主要メーカー別ヒト用ベロ細胞狂犬病ワクチン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（フリーズドライ粉末、液体）
- ヒト用ベロ細胞狂犬病ワクチンの種類別販売量
- ヒト用ベロ細胞狂犬病ワクチンの種類別売上
- ヒト用ベロ細胞狂犬病ワクチンの種類別価格
・用途別市場規模（暴露前予防、暴露後予防）
- ヒト用ベロ細胞狂犬病ワクチンの用途別販売量
- ヒト用ベロ細胞狂犬病ワクチンの用途別売上
- ヒト用ベロ細胞狂犬病ワクチンの用途別価格
・北米市場
- 北米のヒト用ベロ細胞狂犬病ワクチン市場規模（種類別、用途別）
- 主要国別のヒト用ベロ細胞狂犬病ワクチン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのヒト用ベロ細胞狂犬病ワクチン市場規模（種類別、用途別）
- 主要国別のヒト用ベロ細胞狂犬病ワクチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のヒト用ベロ細胞狂犬病ワクチン市場規模（種類別、用途別）
- 主要国別のヒト用ベロ細胞狂犬病ワクチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のヒト用ベロ細胞狂犬病ワクチン市場規模（種類別、用途別）
- 主要国別のヒト用ベロ細胞狂犬病ワクチン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのヒト用ベロ細胞狂犬病ワクチン市場規模（種類別、用途別）
- 主要国別のヒト用ベロ細胞狂犬病ワクチン市場規模（トルコ、サウジアラビア）
・企業情報
Bharat Biotech、Sanofi-Pasteur、Chengda Bio、Prcmise、Zhuoyi Biological、Ningbo Rongan Biological、Indian Immunologicals
・産業チェーン及び販売チャネル分析
- ヒト用ベロ細胞狂犬病ワクチンの産業チェーン分析
- ヒト用ベロ細胞狂犬病ワクチンの原材料
- ヒト用ベロ細胞狂犬病ワクチンの生産プロセス
- ヒト用ベロ細胞狂犬病ワクチンの販売及びマーケティング
- ヒト用ベロ細胞狂犬病ワクチンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ヒト用ベロ細胞狂犬病ワクチンの産業動向
- ヒト用ベロ細胞狂犬病ワクチンのマーケットドライバー
- ヒト用ベロ細胞狂犬病ワクチンの課題
- ヒト用ベロ細胞狂犬病ワクチンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Vero Cell Rabies Vaccines for Human Market
Due to the COVID-19 pandemic, the global Vero Cell Rabies Vaccines for Human market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Freeze-dried Powder accounting for % of the Vero Cell Rabies Vaccines for Human global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pre-exposure Prophylaxis segment is altered to an % CAGR throughout this forecast period.
China Vero Cell Rabies Vaccines for Human market size is valued at US$ million in 2021, while the US and Europe Vero Cell Rabies Vaccines for Human are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vero Cell Rabies Vaccines for Human landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Vero Cell Rabies Vaccines for Human include Bharat Biotech, Sanofi-Pasteur, Chengda Bio, Prcmise, Zhuoyi Biological, Ningbo Rongan Biological and Indian Immunologicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Vero Cell Rabies Vaccines for Human Scope and Segment
Vero Cell Rabies Vaccines for Human market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Vero Cell Rabies Vaccines for Human market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Freeze-dried Powder
Liquid
Segment by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
By Company
Bharat Biotech
Sanofi-Pasteur
Chengda Bio
Prcmise
Zhuoyi Biological
Ningbo Rongan Biological
Indian Immunologicals
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Vero Cell Rabies Vaccines for Human Product Introduction
1.2 Market by Type
1.2.1 Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Freeze-dried Powder
1.2.3 Liquid
1.3 Market by Application
1.3.1 Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vero Cell Rabies Vaccines for Human Sales Estimates and Forecasts 2017-2028
2.2 Global Vero Cell Rabies Vaccines for Human Revenue Estimates and Forecasts 2017-2028
2.3 Global Vero Cell Rabies Vaccines for Human Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vero Cell Rabies Vaccines for Human Sales by Region
2.4.1 Global Vero Cell Rabies Vaccines for Human Sales by Region (2017-2022)
2.4.2 Global Sales Vero Cell Rabies Vaccines for Human by Region (2023-2028)
2.5 Global Vero Cell Rabies Vaccines for Human Revenue by Region
2.5.1 Global Vero Cell Rabies Vaccines for Human Revenue by Region (2017-2022)
2.5.2 Global Vero Cell Rabies Vaccines for Human Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vero Cell Rabies Vaccines for Human Sales by Manufacturers
3.1.1 Global Top Vero Cell Rabies Vaccines for Human Manufacturers by Sales (2017-2022)
3.1.2 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vero Cell Rabies Vaccines for Human in 2021
3.2 Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturers
3.2.1 Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturers (2017-2022)
3.2.2 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vero Cell Rabies Vaccines for Human Revenue in 2021
3.3 Global Vero Cell Rabies Vaccines for Human Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vero Cell Rabies Vaccines for Human Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Vero Cell Rabies Vaccines for Human Sales by Type
4.1.1 Global Vero Cell Rabies Vaccines for Human Historical Sales by Type (2017-2022)
4.1.2 Global Vero Cell Rabies Vaccines for Human Forecasted Sales by Type (2023-2028)
4.1.3 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2017-2028)
4.2 Global Vero Cell Rabies Vaccines for Human Revenue by Type
4.2.1 Global Vero Cell Rabies Vaccines for Human Historical Revenue by Type (2017-2022)
4.2.2 Global Vero Cell Rabies Vaccines for Human Forecasted Revenue by Type (2023-2028)
4.2.3 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2017-2028)
4.3 Global Vero Cell Rabies Vaccines for Human Price by Type
4.3.1 Global Vero Cell Rabies Vaccines for Human Price by Type (2017-2022)
4.3.2 Global Vero Cell Rabies Vaccines for Human Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Vero Cell Rabies Vaccines for Human Sales by Application
5.1.1 Global Vero Cell Rabies Vaccines for Human Historical Sales by Application (2017-2022)
5.1.2 Global Vero Cell Rabies Vaccines for Human Forecasted Sales by Application (2023-2028)
5.1.3 Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2017-2028)
5.2 Global Vero Cell Rabies Vaccines for Human Revenue by Application
5.2.1 Global Vero Cell Rabies Vaccines for Human Historical Revenue by Application (2017-2022)
5.2.2 Global Vero Cell Rabies Vaccines for Human Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2017-2028)
5.3 Global Vero Cell Rabies Vaccines for Human Price by Application
5.3.1 Global Vero Cell Rabies Vaccines for Human Price by Application (2017-2022)
5.3.2 Global Vero Cell Rabies Vaccines for Human Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vero Cell Rabies Vaccines for Human Market Size by Type
6.1.1 North America Vero Cell Rabies Vaccines for Human Sales by Type (2017-2028)
6.1.2 North America Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2028)
6.2 North America Vero Cell Rabies Vaccines for Human Market Size by Application
6.2.1 North America Vero Cell Rabies Vaccines for Human Sales by Application (2017-2028)
6.2.2 North America Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2028)
6.3 North America Vero Cell Rabies Vaccines for Human Market Size by Country
6.3.1 North America Vero Cell Rabies Vaccines for Human Sales by Country (2017-2028)
6.3.2 North America Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Vero Cell Rabies Vaccines for Human Market Size by Type
7.1.1 Europe Vero Cell Rabies Vaccines for Human Sales by Type (2017-2028)
7.1.2 Europe Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2028)
7.2 Europe Vero Cell Rabies Vaccines for Human Market Size by Application
7.2.1 Europe Vero Cell Rabies Vaccines for Human Sales by Application (2017-2028)
7.2.2 Europe Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2028)
7.3 Europe Vero Cell Rabies Vaccines for Human Market Size by Country
7.3.1 Europe Vero Cell Rabies Vaccines for Human Sales by Country (2017-2028)
7.3.2 Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vero Cell Rabies Vaccines for Human Market Size by Type
8.1.1 Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Type (2017-2028)
8.1.2 Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2028)
8.2 Asia Pacific Vero Cell Rabies Vaccines for Human Market Size by Application
8.2.1 Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Application (2017-2028)
8.2.2 Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2028)
8.3 Asia Pacific Vero Cell Rabies Vaccines for Human Market Size by Region
8.3.1 Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2017-2028)
8.3.2 Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Vero Cell Rabies Vaccines for Human Market Size by Type
9.1.1 Latin America Vero Cell Rabies Vaccines for Human Sales by Type (2017-2028)
9.1.2 Latin America Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2028)
9.2 Latin America Vero Cell Rabies Vaccines for Human Market Size by Application
9.2.1 Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2017-2028)
9.2.2 Latin America Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2028)
9.3 Latin America Vero Cell Rabies Vaccines for Human Market Size by Country
9.3.1 Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2017-2028)
9.3.2 Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Size by Type
10.1.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Type (2017-2028)
10.1.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2028)
10.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Size by Application
10.2.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2028)
10.3 Middle East and Africa Vero Cell Rabies Vaccines for Human Market Size by Country
10.3.1 Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bharat Biotech
11.1.1 Bharat Biotech Corporation Information
11.1.2 Bharat Biotech Overview
11.1.3 Bharat Biotech Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bharat Biotech Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bharat Biotech Recent Developments
11.2 Sanofi-Pasteur
11.2.1 Sanofi-Pasteur Corporation Information
11.2.2 Sanofi-Pasteur Overview
11.2.3 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi-Pasteur Recent Developments
11.3 Chengda Bio
11.3.1 Chengda Bio Corporation Information
11.3.2 Chengda Bio Overview
11.3.3 Chengda Bio Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chengda Bio Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengda Bio Recent Developments
11.4 Prcmise
11.4.1 Prcmise Corporation Information
11.4.2 Prcmise Overview
11.4.3 Prcmise Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Prcmise Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Prcmise Recent Developments
11.5 Zhuoyi Biological
11.5.1 Zhuoyi Biological Corporation Information
11.5.2 Zhuoyi Biological Overview
11.5.3 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhuoyi Biological Recent Developments
11.6 Ningbo Rongan Biological
11.6.1 Ningbo Rongan Biological Corporation Information
11.6.2 Ningbo Rongan Biological Overview
11.6.3 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ningbo Rongan Biological Recent Developments
11.7 Indian Immunologicals
11.7.1 Indian Immunologicals Corporation Information
11.7.2 Indian Immunologicals Overview
11.7.3 Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Indian Immunologicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vero Cell Rabies Vaccines for Human Industry Chain Analysis
12.2 Vero Cell Rabies Vaccines for Human Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vero Cell Rabies Vaccines for Human Production Mode & Process
12.4 Vero Cell Rabies Vaccines for Human Sales and Marketing
12.4.1 Vero Cell Rabies Vaccines for Human Sales Channels
12.4.2 Vero Cell Rabies Vaccines for Human Distributors
12.5 Vero Cell Rabies Vaccines for Human Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vero Cell Rabies Vaccines for Human Industry Trends
13.2 Vero Cell Rabies Vaccines for Human Market Drivers
13.3 Vero Cell Rabies Vaccines for Human Market Challenges
13.4 Vero Cell Rabies Vaccines for Human Market Restraints
14 Key Findings in The Global Vero Cell Rabies Vaccines for Human Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Freeze-dried Powder
Table 3. Major Manufacturers of Liquid
Table 4. Global Vero Cell Rabies Vaccines for Human Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vero Cell Rabies Vaccines for Human Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Vero Cell Rabies Vaccines for Human Sales by Region (2017-2022) & (K Units)
Table 7. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2017-2022)
Table 8. Global Vero Cell Rabies Vaccines for Human Sales by Region (2023-2028) & (K Units)
Table 9. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2023-2028)
Table 10. Global Vero Cell Rabies Vaccines for Human Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2017-2022)
Table 12. Global Vero Cell Rabies Vaccines for Human Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region (2023-2028)
Table 14. Global Vero Cell Rabies Vaccines for Human Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Vero Cell Rabies Vaccines for Human Sales Share by Manufacturers (2017-2022)
Table 16. Global Vero Cell Rabies Vaccines for Human Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Vero Cell Rabies Vaccines for Human Revenue Share by Manufacturers (2017-2022)
Table 18. Vero Cell Rabies Vaccines for Human Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Vero Cell Rabies Vaccines for Human Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Vero Cell Rabies Vaccines for Human by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vero Cell Rabies Vaccines for Human as of 2021)
Table 21. Vero Cell Rabies Vaccines for Human Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vero Cell Rabies Vaccines for Human Product Offered
Table 23. Date of Manufacturers Enter into Vero Cell Rabies Vaccines for Human Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vero Cell Rabies Vaccines for Human Sales by Type (2017-2022) & (K Units)
Table 26. Global Vero Cell Rabies Vaccines for Human Sales by Type (2023-2028) & (K Units)
Table 27. Global Vero Cell Rabies Vaccines for Human Sales Share by Type (2017-2022)
Table 28. Global Vero Cell Rabies Vaccines for Human Sales Share by Type (2023-2028)
Table 29. Global Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Vero Cell Rabies Vaccines for Human Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Vero Cell Rabies Vaccines for Human Revenue Share by Type (2017-2022)
Table 32. Global Vero Cell Rabies Vaccines for Human Revenue Share by Type (2023-2028)
Table 33. Vero Cell Rabies Vaccines for Human Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Vero Cell Rabies Vaccines for Human Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Vero Cell Rabies Vaccines for Human Sales by Application (2017-2022) & (K Units)
Table 36. Global Vero Cell Rabies Vaccines for Human Sales by Application (2023-2028) & (K Units)
Table 37. Global Vero Cell Rabies Vaccines for Human Sales Share by Application (2017-2022)
Table 38. Global Vero Cell Rabies Vaccines for Human Sales Share by Application (2023-2028)
Table 39. Global Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Vero Cell Rabies Vaccines for Human Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Vero Cell Rabies Vaccines for Human Revenue Share by Application (2017-2022)
Table 42. Global Vero Cell Rabies Vaccines for Human Revenue Share by Application (2023-2028)
Table 43. Vero Cell Rabies Vaccines for Human Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Vero Cell Rabies Vaccines for Human Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Vero Cell Rabies Vaccines for Human Sales by Type (2017-2022) & (K Units)
Table 46. North America Vero Cell Rabies Vaccines for Human Sales by Type (2023-2028) & (K Units)
Table 47. North America Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Vero Cell Rabies Vaccines for Human Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Vero Cell Rabies Vaccines for Human Sales by Application (2017-2022) & (K Units)
Table 50. North America Vero Cell Rabies Vaccines for Human Sales by Application (2023-2028) & (K Units)
Table 51. North America Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Vero Cell Rabies Vaccines for Human Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Vero Cell Rabies Vaccines for Human Sales by Country (2017-2022) & (K Units)
Table 54. North America Vero Cell Rabies Vaccines for Human Sales by Country (2023-2028) & (K Units)
Table 55. North America Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Vero Cell Rabies Vaccines for Human Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Vero Cell Rabies Vaccines for Human Sales by Type (2017-2022) & (K Units)
Table 58. Europe Vero Cell Rabies Vaccines for Human Sales by Type (2023-2028) & (K Units)
Table 59. Europe Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Vero Cell Rabies Vaccines for Human Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2017-2022) & (K Units)
Table 62. Europe Vero Cell Rabies Vaccines for Human Sales by Application (2023-2028) & (K Units)
Table 63. Europe Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Vero Cell Rabies Vaccines for Human Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2017-2022) & (K Units)
Table 66. Europe Vero Cell Rabies Vaccines for Human Sales by Country (2023-2028) & (K Units)
Table 67. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Vero Cell Rabies Vaccines for Human Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Vero Cell Rabies Vaccines for Human Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Vero Cell Rabies Vaccines for Human Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Vero Cell Rabies Vaccines for Human Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Vero Cell Rabies Vaccines for Human Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Vero Cell Rabies Vaccines for Human Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Vero Cell Rabies Vaccines for Human Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Vero Cell Rabies Vaccines for Human Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Vero Cell Rabies Vaccines for Human Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue by Country (2023-2028) & (US$ Million)
Table 105. Bharat Biotech Corporation Information
Table 106. Bharat Biotech Description and Major Businesses
Table 107. Bharat Biotech Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Bharat Biotech Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Bharat Biotech Recent Developments
Table 110. Sanofi-Pasteur Corporation Information
Table 111. Sanofi-Pasteur Description and Major Businesses
Table 112. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Sanofi-Pasteur Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Sanofi-Pasteur Recent Developments
Table 115. Chengda Bio Corporation Information
Table 116. Chengda Bio Description and Major Businesses
Table 117. Chengda Bio Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Chengda Bio Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Chengda Bio Recent Developments
Table 120. Prcmise Corporation Information
Table 121. Prcmise Description and Major Businesses
Table 122. Prcmise Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Prcmise Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Prcmise Recent Developments
Table 125. Zhuoyi Biological Corporation Information
Table 126. Zhuoyi Biological Description and Major Businesses
Table 127. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Zhuoyi Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Zhuoyi Biological Recent Developments
Table 130. Ningbo Rongan Biological Corporation Information
Table 131. Ningbo Rongan Biological Description and Major Businesses
Table 132. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 133. Ningbo Rongan Biological Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Ningbo Rongan Biological Recent Developments
Table 135. Indian Immunologicals Corporation Information
Table 136. Indian Immunologicals Description and Major Businesses
Table 137. Indian Immunologicals Vero Cell Rabies Vaccines for Human Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 138. Indian Immunologicals Vero Cell Rabies Vaccines for Human Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Indian Immunologicals Recent Developments
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Vero Cell Rabies Vaccines for Human Distributors List
Table 143. Vero Cell Rabies Vaccines for Human Customers List
Table 144. Vero Cell Rabies Vaccines for Human Market Trends
Table 145. Vero Cell Rabies Vaccines for Human Market Drivers
Table 146. Vero Cell Rabies Vaccines for Human Market Challenges
Table 147. Vero Cell Rabies Vaccines for Human Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Vero Cell Rabies Vaccines for Human Product Picture
Figure 3. Global Vero Cell Rabies Vaccines for Human Market Share by Type in 2021 & 2028
Figure 3. Freeze-dried Powder Product Picture
Figure 4. Liquid Product Picture
Figure 5. Global Vero Cell Rabies Vaccines for Human Market Share by Application in 2021 & 2028
Figure 6. Pre-exposure Prophylaxis
Figure 7. Post-exposure Prophylaxis
Figure 8. Vero Cell Rabies Vaccines for Human Report Years Considered
Figure 9. Global Vero Cell Rabies Vaccines for Human Sales 2017-2028 (K Units)
Figure 10. Global Vero Cell Rabies Vaccines for Human Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Vero Cell Rabies Vaccines for Human Revenue 2017-2028 (US$ Million)
Figure 12. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2017-2022)
Figure 14. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Region (2023-2028)
Figure 15. North America Vero Cell Rabies Vaccines for Human Sales YoY (2017-2028) & (K Units)
Figure 16. North America Vero Cell Rabies Vaccines for Human Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Vero Cell Rabies Vaccines for Human Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Vero Cell Rabies Vaccines for Human Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Vero Cell Rabies Vaccines for Human Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Vero Cell Rabies Vaccines for Human Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Vero Cell Rabies Vaccines for Human Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Vero Cell Rabies Vaccines for Human Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Vero Cell Rabies Vaccines for Human Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Vero Cell Rabies Vaccines for Human Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Vero Cell Rabies Vaccines for Human Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Vero Cell Rabies Vaccines for Human in the World: Market Share by Vero Cell Rabies Vaccines for Human Revenue in 2021
Figure 27. Global Vero Cell Rabies Vaccines for Human Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2017-2028)
Figure 29. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2017-2028)
Figure 30. Global Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2017-2028)
Figure 31. Global Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2017-2028)
Figure 32. North America Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2017-2028)
Figure 33. North America Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2017-2028)
Figure 34. North America Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2017-2028)
Figure 35. North America Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2017-2028)
Figure 36. North America Vero Cell Rabies Vaccines for Human Sales Share by Country (2017-2028)
Figure 37. North America Vero Cell Rabies Vaccines for Human Revenue Share by Country (2017-2028)
Figure 38. United States Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2017-2028)
Figure 41. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2017-2028)
Figure 42. Europe Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2017-2028)
Figure 43. Europe Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2017-2028)
Figure 44. Europe Vero Cell Rabies Vaccines for Human Sales Share by Country (2017-2028)
Figure 45. Europe Vero Cell Rabies Vaccines for Human Revenue Share by Country (2017-2028)
Figure 46. Germany Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 47. France Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 48. U.K. Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Vero Cell Rabies Vaccines for Human Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Vero Cell Rabies Vaccines for Human Revenue Share by Region (2017-2028)
Figure 57. China Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 60. India Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2017-2028)
Figure 67. Latin America Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2017-2028)
Figure 69. Latin America Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Vero Cell Rabies Vaccines for Human Sales Share by Country (2017-2028)
Figure 71. Latin America Vero Cell Rabies Vaccines for Human Revenue Share by Country (2017-2028)
Figure 72. Mexico Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 75. Colombia Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Vero Cell Rabies Vaccines for Human Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Vero Cell Rabies Vaccines for Human Revenue Share by Country (2017-2028)
Figure 82. Turkey Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Vero Cell Rabies Vaccines for Human Revenue (2017-2028) & (US$ Million)
Figure 85. Vero Cell Rabies Vaccines for Human Value Chain
Figure 86. Vero Cell Rabies Vaccines for Human Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed

以下、関連資料のご紹介

人用狂犬病ワクチンの世界市場2022年-2030年

Human Rabies Vaccines Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
SRT22JL0332 2022年5月 135Pages
Straits Research社発行の当調査レポートでは、世界の人用狂犬病ワクチン市場について広範囲に分析し、市場概要、関連企業、種類別、用途別、アジア太平洋市場、ヨーロッパ市場、北米市場、南米市場、中東・アフリカ市場などの地域分析を含めた項目を掲載しています。なお、当レポートに掲載されている主要...

VERO培地のグローバル市場インサイト・予測（～2028年）

Global VERO Medium Market Insights, Forecast to 2028
QY2207E10243 2022年7月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界のVERO培地の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にVERO培地の世界市場の...

世界の動物用狂犬病ワクチン市場予測（～2028年）：注射用ワクチン、経口ワクチン

Global Animal Rabies Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
GIR-22E8729 2022年5月 99Pages
動物用狂犬病ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します...

水産用ワクチンのグローバル市場インサイト・予測（～2028年）

Global Aqua Vaccines Market Insights, Forecast to 2028
QY2207E09441 2022年7月 88Pages
新型コロナウイルス感染症のパンデミックにより、世界の水産用ワクチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に水産用ワクチンの世界市...

家畜用ワクチンのグローバル市場インサイト・予測（～2028年）

Global Livestock Vaccines Market Insights, Forecast to 2028
QY2207E10398 2022年7月 112Pages
新型コロナウイルス感染症のパンデミックにより、世界の家畜用ワクチンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に家畜用ワクチンの世界市...

人用狂犬病ワクチンの世界市場2022年-2030年 Summary: In this Human Rabies Vaccines Market report, offers a comprehensive analysis of key market trends in the global Human Rabies Vaccines market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed …
VERO培地のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global VERO Medium Market Due to the COVID-19 pandemic, the global VERO Medium market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering t…
世界の動物用狂犬病ワクチン市場予測（～2028年）：注射用ワクチン、経口ワクチン The Animal Rabies Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
水産用ワクチンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Aqua Vaccines Market Due to the COVID-19 pandemic, the global Aqua Vaccines market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully consideri…
新型コロナウイルス感染症ワクチンの世界市場2022年-2030年 Summary: In this COVID-19 Vaccines Market report, offers a comprehensive analysis of key market trends in the global COVID-19 Vaccines market. It also includes discussion on historical trends, current market status, competitive landscape, growth opportunities and challenges which are backed by factf…